0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
REGULAR ARTICLES   |    
Binge Eating in Parkinson's Disease: Prevalence, Correlates and the Contribution of Deep Brain Stimulation
Laura B. Zahodne, M.S.; Frandy Susatia, M.D.; Dawn Bowers, Ph.D.; Tiara L. Ong, B.A.; Charles E. Jacobson, IV, B.S.; Michael S. Okun, M.D.; Ramon L. Rodriguez, M.D.; Irene A. Malaty, M.D.; Kelly D. Foote, M.D.; Hubert H. Fernandez, M.D.
The Journal of Neuropsychiatry and Clinical Neurosciences 2011;23:56-62.
View Author and Article Information

Ms. Zahodne and Dr. Bowers are affiliated with the Dept. of Clinical & Health Psychology, Drs. Susatia, Okun, Rodriguez, and Malaty and Ms. Ong and Mr. Jacobson are in the Dept. of Neurology, Drs. Foote and Okun are in the Dept. of Neurosurgery, all at the University of Florida in Gainesville, FL; Dr. Fernandez is affiliated with the Center for Neurological Restoration at the Cleveland Clinic.

Address correspondence to Hubert H. Fernandez, M.D., Center for Neurological Restoration, Cleveland Clinic,9500 Euclid Ave., S-31, Cleveland, OH 44195. e-mail: fernanh@ccf.org

Received November 23, 2009; Revised January 28, 2010; Accepted February 12, 2010.

Of 96 Parkinson's disease patients surveyed at the University of Florida Movement Disorders Center, one (1%) met diagnostic criteria for binge-eating disorder. Eight (8.3%) exhibited subthreshold binge eating. Psychometric criteria classified problem gambling in 17.8%, hoarding in 8.3%, compulsive buying in 11.5%, hypersexuality in 1.0%, and mania in 1.0% of patients. More overeaters met psychometric criteria for at least one additional impulse-control disorder (67% versus 29%). No more overeaters than non-overeaters were taking a dopamine agonist (44% versus 41%). More overeaters had a history of subthalamic deep brain stimulation (DBS; 44% versus 14%). History of DBS was the only independent predictor of overeating.

Abstract Teaser
Figures in this Article

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the prominent loss of dopamine neurons in the substantia nigra pars compacta. Although first recognized as a purely motor disorder featuring resting tremor, rigidity, bradykinesia, and postural instability, PD is increasingly being conceptualized as a neuropsychiatric disorder because of the high prevalence of nonmotor symptoms.1 Psychiatric features include depression, apathy, anxiety, psychosis, and sleep disturbance.

Recent studies have identified a subpopulation of PD patients who exhibit impulsive and compulsive behaviors, such as pathological gambling, hypersexuality, compulsive shopping, punding, and binge-eating.2 Many consider impulse-control disorders (ICDs) to result purely from iatrogenic factors, and symptoms often subside when dopaminergic medications are reduced or replaced. However, several patient factors have been variably linked to ICD manifestation, including male sex, younger age at PD onset, personal or family history of substance abuse or other psychiatric disorders, and a personality style characterized by impulsiveness.3,4 True prevalence rates for ICDs in Parkinson's disease are not well established;4 however, preliminary evidence supports the idea that that ICDs are more common in Parkinson's disease than in the general population or in healthy-control subjects. Prevalence estimates range from 0.4% to 10%, depending on the specific ICD.5 Although several authors have described the phenomenon of binge-eating among PD patients, no reliable point-prevalence estimates have been reported.4 With regard to the general population, a recently completed, multi-national study identified binge-eating disorder in 1.12% of over 20,000 European participants.6

DSM-IV defines binge-eating disorder as eating an amount of food that is definitely larger than most people would eat during the same period of time under similar circumstances, coupled with a perceived lack of control over one's eating (criterion A). Patients with binge-eating disorder must exhibit marked distress regarding binge-eating (criterion C), and three out of five associated features (criterion B). Binge-eating episodes must occur at least twice weekly for a 6-month period (criterion D), and individuals must not engage in inappropriate compensatory behaviors, such as purging or fasting (criterion E). Many researchers have recently supported the consideration of subthreshold eating disorders in the case of individuals who fail to meet all of the above DSM-IV criteria.6,7 The purpose of the present prospective study was to determine the prevalence of and factors associated with binge-eating disorder and subthreshold binge-eating in Parkinson's disease.

+

Participants

One hundred consecutive PD patients were approached during regularly scheduled follow-up visits at the University of Florida Movement Disorders Clinic, from September to December 2008. All patients carried a current diagnosis of idiopathic Parkinson's disease, based on United Kingdom Parkinson's Disease Society Brain Bank Diagnostic Criteria for Parkinson's Disease.8 We excluded all patients with uncontrolled hypo/hyperthyroidism, brittle diabetes mellitus, or significant medical issues that could affect normal dietary habits within the last 60 days before the survey.

+

Procedures

Demographic and disease characteristics were obtained directly from patients and their caregivers. Motor severity was assessed by clinicians specializing in movement disorders using the Unified Parkinson Disease Rating Scale (UPDRS-III). All patients were administered quality-of-life, cognitive, and behavioral assessments, including the Parkinson Disease Questionnaire (PDQ-39), the Beck Depression Inventory-II (BDI-II), the State–Trait Anxiety Inventory, the Apathy Scale, and the Mini-Mental State Exam (MMSE).912 Next, all patients completed a battery of tests assessing impulsive and compulsive behaviors, as described below. All procedures were approved by the local Institutional Review Board at the University of Florida.

+

Measures

Impulsive and compulsive behaviors were assessed with a battery of well-validated self-report questionnaires. The Barratt Impulsiveness Scale (BIS-11) contains 30 Likert-type items, and higher scores indicate greater general impulsivity.13 The Yale-Brown Obsessive-Compulsive Scale contains 19 items, and only the first 10 Likert-type items contribute to the total score.14 Scores of 0 to 7 indicate “subclinical” symptoms. The Young Mania Rating Scale contains 11 Likert-type items, and scores above 20 indicate significant symptoms.15 The South Oak Gambling Screen contains 16 items of varying formats.16 Total score is determined by the number of “at-risk” responses. Scores of 1 to 4 indicate “some problems” with gambling, and scores above 4 indicate “probable pathological” gambling. The Sexual Compulsivity Scale contains 10 Likert-type items.17 Suggested cut-scores for elevated sexual compulsivity are 2.1 for men and 1.7 for women. The Saving Inventory–Revised contains 23 Likert-type items and yields a global score and three subscale scores: Clutter, Acquisition, and Difficulty Discarding.18 A global score above 40 indicates significant hoarding. The Problematic Internet Use Questionnaire contains 18 Likert-type items and yields a global score and three subscale scores: Obsession, Neglect, and Control Disorder.19 A global score above 42.4 indicates significant problems. The Valence Compulsive Buying Scale contains 13 Likert-type items.20 Compulsive buyers tend to score 42.2 or higher.

Eating behaviors were assessed with the Eating Disorder Examination Questionnaire (EDE-Q) and the Eating Disorder Diagnostic Scale (EDDS).21,22 The EDE-Q is a 36-item self-report measure adapted from the Eating Disorder Examination interview that features a 7-point Likert-type scale. The EDDS is a 22-item self-report questionnaire containing both Yes/No items and Likert-type scales. It assesses DSM-IV criteria A–E for binge-eating disorder. In the present study, responses on the EDDS were used to identify the presence of binge-eating disorder, based on DSM-IV criteria: 1) yes to Items 5 and 6; 2) yes to at least 3 of Items 9–13; 3) yes to Item 14; 4) a score of at least 2 on Item 7; and 5) scores of 0 on Items 15–18. Patients who met criteria 1 and 5 and reported at least weekly binge-eating episodes over the previous 6 months but who failed to meet one or more of the additional criteria were identified as having subthreshold binge-eating disorder.6,7

+

Statistical Analyses

Descriptive statistics were used to characterize the sample. Relationships between variables were initially explored using Pearson correlations. Nonparametric Mann-Whitney U tests were used to compare overeaters and non-overeaters on a variety of demographic, disease, and psychological characteristics. Categorical variables were analyzed with chi-square tests. The independent influences of selected variables on overeating status were examined with hierarchical binary logistic regression.

Of 100 consecutive patients approached, 96 patients completed the study. The four patients who declined to participate all cited the number of questionnaires as their reason for refusal. Demographic and disease characteristics of the sample are shown in Table 1. Of these 96 patients, 22 (22.9%) had previously undergone deep brain stimulation (DBS) surgery in either the internal globus pallidus (6%) or the subthalamic nucleus (17%), whereas 74 (77.1%) were exclusively medically managed. Approximately 42% of patients were taking a dopamine agonist when assessed. On average, patients did not have dementia or depression. Only one patient scored below the cutoff for dementia (MMSE score <24). Seventeen patients evidenced mild-to-moderate depression (BDI score >14).

 
Anchor for Jump
TABLE 1.Demographics, Disease Characteristics, and Group Comparisons

According to responses on the Eating Disorder Diagnostic Scale, one patient met full diagnostic criteria for binge-eating disorder (1%). An additional 8 patients (8.3%) exhibited subthreshold binge-eating in that they all met criteria A and E for binge-eating disorder. Five patients did not meet criterion B; 2 patients did not meet criterion C; and 1 patient did not meet criteria B, C, or D. This latter individual reported weekly episodes over the last 6 months.

The severity of disordered eating habits was quantified using Eating Disorder Examination Questionnaire global scores. In the entire sample, disordered eating correlated with general impulsiveness (r=0.585; p<0.001) and mania (r=0.366; p<0.001). No significant correlations were noted between disordered eating and any of the demographic, disease, or psychological variables. Table 1 shows that overeaters (N=9) did not differ from non-overeaters (N=87) on any demographic, motor, or mood variables. However, overeaters endorsed greater amounts of overall disordered eating, impulsivity, mania, and clutter behaviors than non-overeaters.

Using psychometric criteria described by the individual scales' developers, the prevalence of impulse control behaviors other than binge eating was determined. Note that DSM-IV clinical criteria were not used to categorize individuals, as a complete diagnostic interview for these other impulse controls disorders was not part of the present protocol. Six patients (6.25%) were identified as probable pathological gamblers; an additional 11 patients (11.5%) had problematic gambling. Eight patients (8.3%) had compulsive hoarding; 11 patients (11.5%) had compulsive buying; one patient (1.0%) had hypersexuality; and one patient (1.0%) had clinically significant manic symptoms. No pathologic Internet use, anorexia nervosa, or bulimia nervosa was found.

Next, we examined whether overeaters were more likely than non-overeaters to demonstrate other impulse-control behaviors. Table 2 displays the number of overeaters and non-overeaters who met psychometric criteria in one or more of these domains. As shown, overeaters were more likely than non-overeaters to report mania, hoarding, hypersexuality, and compulsive buying. There was a trend for overeaters to be more likely than non-overeaters to exhibit significant obsessive-compulsive features. Six of the nine overeaters (67%) met psychometric criteria for at least one other ICD, versus 25 out of 87 non-overeaters (29%). This difference was significant (χ2=5.367; df=1; φ=0.236; p=0.02).

 
Anchor for Jump
TABLE 2.Proportions of Individuals Meeting Criteria for Other Impulse-Control Psychopathology

Four of the nine overeaters (44%) were currently on an agonist, versus 41% of control subjects, and this difference was not statistically significant. Four out of nine overeaters (44%) had undergone subthalamic nucleus DBS surgery, and 0 had undergone internal globus pallidus DBS. Twelve (14%) and six (7%) non-overeaters had undergone DBS in the subthalamic nucleus and internal globus pallidus, respectively. The association between overeating and DBS history (subthalamic nucleus, internal globus pallidus or no DBS) was at trend level (χ2=5.82; df=2; Cramer's V=0.246; p=0.055).

In order to determine the relative contributions of demographic, disease, and iatrogenic variables to overeating, a hierarchical logistic regression was conducted, in which the dependent variable was eating status (Overeater versus Non-overeater). Based on previous research, the first block comprised iatrogenic variables (DBS, dopamine-agonist therapy, l-dopa equivalent daily dose [LEDD]). The second block comprised disease characteristics (age at PD onset, UPDRS-III total score), and the third block comprised demographic characteristics (age, sex, education). Results are shown in Table 3. Although the model did not reach significance at any of the three steps, DBS emerged as the only independent predictor of being Overeater status at all three steps (p=0.023 after Step 1; p=0.021 after Step 2; and p=0.019 after Step 3).

 
Anchor for Jump
TABLE 3.Hierarchical Logistic-Regression Results

Our study is cross-sectional, with all of its inherent weaknesses. Nonetheless, the present report describes results from the first prospective study on the point prevalence of binge-eating disorder in Parkinson's disease patients in the United States. It provides further support for a relationship between binge-eating and other behaviors on the impulsive-compulsive spectrum. Results also suggest that future research should explicitly examine the contribution of deep brain stimulation in the subthalamic nucleus to binge-eating behaviors.

We identified the presence of binge-eating disorder in only 1% of our unselected sample of 96 consecutive PD patients, which is comparable to the 1.12% prevalence estimate reported in a recent multinational study.6 In the future, a larger sample size should be used to confirm this prevalence value. The current estimate of binge-eating disorder prevalence is lower than those reported for pathological gambling and hypersexuality and higher than that reported for compulsive buying in PD.2 Despite the lack of higher prevalence of binge-eating disorder in this sample of PD patients, we identified subclinical binge-eating disorder in 8% of the sample, which is similar to or higher than rates of other ICDs.2 Using psychometric criteria, we also identified relatively high levels of problem gambling (11.5%), compulsive buying (11.5%), and hoarding (8.3%) within our sample.

We found substantial support for the co-occurrence of ICD behaviors among individuals with Parkinson's disease. Binge-eating severity correlated with measures of impulsivity and mania. More overeaters met psychometric criteria for at least one other ICD than did non-overeaters. This overlap is consistent with the current view of a common pathophysiological mechanism underlying these behaviors in PD that involve mesocorticolimbic sensitization. Recent neurobiological experiments show enhanced dopaminergic activity within the ventral striatum of PD patients displaying pathological gambling or dopamine dysregulation syndrome (DDS).23

Previous studies have variably identified male sex, younger age at PD onset, and depression as risk factors for ICDs.2 In our sample, overeaters and non-overeaters did not differ on any of these variables. However, most previous studies focused on pathological gambling. Many have failed to identify these variables as independent risk factors when using multivariate analyses.4,5 No study has yet examined the contributions of these variables exclusively to binge-eating in Parkinson's disease. Of note, a recent mail-survey study involving 312 PD patients similarly failed to identify male sex, mean daily l-dopa dose, or age at Parkinson's disease onset as statistically significant predictors of ICD behaviors.24 These results suggest that additional risk factors for these symptoms must be explored.

Surprisingly, we did not find any association between the use of dopamine agonists and the presence of binge-eating. Multiple studies have implicated dopamine agonists acting on D3 receptors in the pathophysiology of ICDs and repetitive behavior in Parkinson's disease.4,5,24,25 However, confounding variables such as differing prescribing practices may have contributed to initial findings.26 A recent meta-analysis failed to demonstrate a significant relationship between ICDs and individual dopamine agonists.27 A significant percentage of our cohort underwent deep brain stimulation surgery, which could have altered the patients' medication regimen postsurgery.

This study identified a history of subthalamic nucleus DBS surgery as the only significant predictor of binge-eating in a nonselected sample of consecutive PD patients. Furthermore, there was a trend for an association between subthalamic nucleus DBS and being an overeater. However, because the present study did not systematically measure and compare ICD symptomatology before and after surgery, it cannot be concluded that DBS induced binge-eating in these patients. Identification of such a relationship requires future prospective studies with matched controls. None of the four overeaters with a history of subthalamic nucleus DBS carried a psychiatric diagnosis before surgery. However, it is not known whether they demonstrated subclinical symptoms. Of note, two of these four overeaters described an increase in their desire for sweets (i.e., candies and ice cream) after DBS.

Reports of the effects of DBS on impulsive and compulsive behaviors have been somewhat conflicting and have included descriptions of worsened, improved, and newly-developed ICDs after surgery.2831 All four overeaters with a history of DBS in the present study were implanted in the subthalamic nucleus, and it has been suggested that subthalamic nucleus DBS results in more nonmotor complications than DBS in other targets.32,33 Further controlled studies are needed to determine the specificity of our findings to DBS in the subthalamic nucleus. Interestingly, recent experimental evidence has shown that high-frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic regions such as the nucleus accumbens shell, which has been implicated in the pathophysiology of ICDs.34

Weight-gain after DBS has been documented by numerous groups.35 Bilateral and unilateral subthalamic nucleus stimulation have been associated with weight-gains of approximately 10 kg and 4 kg after 1 year, respectively.35 Postsurgical weight-gain has been attributed to medication reduction, improved ability to eat, and/or decreased basal energy expenditure.36 Despite reports of uncontrolled appetitive behaviors after DBS, the potential effect of increased frequency of binge-eating episodes has not yet been systematically evaluated.

The relatively high prevalence of clinical and subclinical symptomatology reported here suggests that physicians should be aware of binge-eating in their PD patients, especially considering the potential adverse consequences of prolonged occurrences. The relationship between binge-eating and weight-gain after DBS surgery should also be elucidated, as it is important for physicians and patients to be cognizant of potential surgical side effects during treatment planning.

National Parkinson Center of Excellence, National Institute on Aging (T32-AG020499 [UF-LBZ]). The authors gratefully acknowledge the work of Janet Romrell, PA-C, for her invaluable assistance with patient recruitment and assessment. This work has already been presented as a poster under this title at the annual meeting of the ANPA.

Simuni  T;  Sethi  K:  Nonmotor manifestations of Parkinson's disease.  Ann Neurol 2008; 64:S65–S80
[PubMed]
[CrossRef]
 
Wolters  E;  van der Werf  YD;  van den Heuvel  OA:  Parkinson's disease-related disorders in the impulsive-compulsive spectrum.  J Neurol 2008; 255:48–56
[PubMed]
[CrossRef]
 
Evans  AH;  Lees  AJ:  Dopamine dysregulation syndrome in Parkinson's disease.  Curr Opin Neurol 2004; 17:393–398
[PubMed]
[CrossRef]
 
Weintraub  D:  Dopamine and impulse control disorders in Parkinson's disease.  Ann Neurol 2008; 64:S93–100
[PubMed]
[CrossRef]
 
Weintraub  D;  Siderowf  AD;  Potenza  MN  et al:  Association of dopamine agonist use with impulse control disorders in Parkinson disease.  Arch Neurol 2006; 63:969–973
[PubMed]
[CrossRef]
 
Preti  A;  de Girolamo  G;  Vilagut  G  et al.  The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project.  J Psychiatr Res 2009; 43:1125–1132
[PubMed]
[CrossRef]
 
Striegel-Moore  RH;  Dohm  FA;  Solomon  EE  et al:  Subthreshold binge eating disorder.  Int J Eat Disord 2000; 27:270–278
[PubMed]
[CrossRef]
 
Hughes  AJ;  Daniel  SE;  Kilford  L  et al:  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.  J Neurol Neurosurg Psychiatry 2002; 55:181–184
[CrossRef]
 
Peto  V;  Jenkinson  C;  Fitzpatrick  R  et al:  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.  Qual Life Res 1995; 4:241–248
[PubMed]
[CrossRef]
 
Beck  AT;  Steer  R;  Brown  G:  The Beck Depression Inventory-II .  San Antonio, Tex,  Psychological Corporation, 1996
 
Spielberger  CD:  Manual for the State-Trait Anxiety Inventory .  Palo Alto, Calif,  Consulting Psychologists Press, 1983
 
Starkstein  SE;  Mayberg  HS;  Preziosi  TJ  et al:  Reliability, validity, and clinical correlates of apathy in Parkinson's disease.  J Neuropsychiatry Clin Neurosci 1992; 4:134–139
[PubMed]
 
Patton  JH;  Stanford  MS;  Barratt  ES:  Factor structure of the Barratt Impulsiveness Scale.  J Clin Psychol 1995; 51:768–774
[PubMed]
[CrossRef]
 
Goodman  WK;  Price  LH;  Rasmussen  SA  et al:  The Yale-Brown Obsessive Compulsive Scale. I: development, use, and reliability.  Arch Gen Psychiatry 1989; 46:1006–1011
[PubMed]
[CrossRef]
 
Young  RC;  Biggs  JT;  Ziegler  VE  et al:  A rating scale for mania: reliability, validity and sensitivity.  Br J Psychiatry 1978; 133:429–435
[PubMed]
[CrossRef]
 
Lesieur  HR;  Blume  SB:  The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers.  Am J Psychiatry 1987; 144:1184–1188
[PubMed]
 
Kalichman  SC;  Rompa  D:  The sexual compulsivity scale: further development and use with HIV-positive persons.  J Pers Assess 2001; 76:379–395
[PubMed]
[CrossRef]
 
Frost  RO;  Steketee  G;  Grisham  J:  Measurement of compulsive hoarding: saving inventory-revised.  Behav Res Ther 2004; 42:1163–1182
[PubMed]
[CrossRef]
 
Demetrovics  Z;  Szeredi  B;  Rózsa  S:  The three-factor model of internet addiction: the development of the Problematic Internet Use Questionnaire.  Behav Res Methods 2008; 40:563–574
[PubMed]
[CrossRef]
 
Valence  G;  d'Astous  A;  Fortier  L:  Compulsive buying: concept and measurement.  J Consum Policy 1988; 11:419–433
[CrossRef]
 
Mond  JM;  Hay  PJ;  Rodgers  B  et al:  Validity of the Eating Disorder Examination Questionnaire (EDE-Q) in screening for eating disorders in community samples.  Behav Res Ther 2004; 42:551–567
[PubMed]
[CrossRef]
 
Stice  E;  Telch  CF;  Rizvi  SL:  Development and validation of the eating disorder diagnostic scale: a brief self-report measure of anorexia, bulimia, and binge-eating disorder.  Psychol Assess 2000; 12:123–131
[PubMed]
[CrossRef]
 
Evans  AH;  Pavese  N;  Lawrence  AD  et al:  Compulsive drug use linked to sensitized ventral striatal dopamine transmission.  Ann Neurol 2006; 59:852–858
[PubMed]
[CrossRef]
 
Fan  W;  Ding  H;  Ma  J  et al:  Impulse control disorders in Parkinson's disease in a Chinese population.  Neurosci Lett 2009; 465:6–9
[PubMed]
[CrossRef]
 
Evans  AH;  Katzenschlager  R;  Pavious  D  et al:  Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.  Mov Disord 2004; 19:397–405
[PubMed]
[CrossRef]
 
Voon  V;  Hassan  K;  Zurowski  M  et al:  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.  Neurology 2006; 67:1254–1257
[PubMed]
[CrossRef]
 
Gallagher  DA;  O'Sullivan  SS;  Evans  AH  et al:  Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation: an analysis of published case series.  Mov Disord 2007; 22:1757–1763
[PubMed]
[CrossRef]
 
Ardouin  C;  Voon  V;  Worbe  Y  et al:  Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.  Mov Disord 2006; 21:1941–1946
[PubMed]
[CrossRef]
 
Frank  MJ;  Samanta  J;  Moustafa  AA  et al:  Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism.  Science 2007; 318:1309–1312
[PubMed]
[CrossRef]
 
Hälbig  TD;  Tse  W;  Frisina  PG  et al:  Subthalamic deep brain stimulation and impulse control in Parkinson's disease.  Eur J Neurol 2009; 16:493–497
[PubMed]
[CrossRef]
 
Smending  HM;  Goudriaan  AE;  Foncke  EM  et al:  Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson's disease.  J Neurol Neurosurg Psychiatry 2007; 78:517–519
[PubMed]
[CrossRef]
 
Okun  MS;  Fernandez  HH;  Wu  SS  et al:  Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus internal deep brain stimulation: the compare trial.  Ann Neurol 2009; 65:586–595
[PubMed]
[CrossRef]
 
Zahodne  LB;  Okun  MS;  Foote  KD  et al:  Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus.  J Neurol 2009; 256:1321–1329
[PubMed]
[CrossRef]
 
Winter  C;  Lemke  C;  Sohr  R  et al:  High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat.  Exp Brain Res 2008; 185:497–507
[PubMed]
[CrossRef]
 
Walker  HC;  Lyerly  M;  Cutter  G  et al:  Weight changes associated with unilateral STN DBS and advanced PD.  Parkinsonism Relat Disord 2009; 15:709–711
[PubMed]
[CrossRef]
 
Montaurier  C;  Morio  B;  Bannier  S  et al:  Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.  Brain 2007; 130:1808–1018
[PubMed]
[CrossRef]
 
References Container
Anchor for Jump
TABLE 1.Demographics, Disease Characteristics, and Group Comparisons
Anchor for Jump
TABLE 2.Proportions of Individuals Meeting Criteria for Other Impulse-Control Psychopathology
Anchor for Jump
TABLE 3.Hierarchical Logistic-Regression Results
+

References

Simuni  T;  Sethi  K:  Nonmotor manifestations of Parkinson's disease.  Ann Neurol 2008; 64:S65–S80
[PubMed]
[CrossRef]
 
Wolters  E;  van der Werf  YD;  van den Heuvel  OA:  Parkinson's disease-related disorders in the impulsive-compulsive spectrum.  J Neurol 2008; 255:48–56
[PubMed]
[CrossRef]
 
Evans  AH;  Lees  AJ:  Dopamine dysregulation syndrome in Parkinson's disease.  Curr Opin Neurol 2004; 17:393–398
[PubMed]
[CrossRef]
 
Weintraub  D:  Dopamine and impulse control disorders in Parkinson's disease.  Ann Neurol 2008; 64:S93–100
[PubMed]
[CrossRef]
 
Weintraub  D;  Siderowf  AD;  Potenza  MN  et al:  Association of dopamine agonist use with impulse control disorders in Parkinson disease.  Arch Neurol 2006; 63:969–973
[PubMed]
[CrossRef]
 
Preti  A;  de Girolamo  G;  Vilagut  G  et al.  The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project.  J Psychiatr Res 2009; 43:1125–1132
[PubMed]
[CrossRef]
 
Striegel-Moore  RH;  Dohm  FA;  Solomon  EE  et al:  Subthreshold binge eating disorder.  Int J Eat Disord 2000; 27:270–278
[PubMed]
[CrossRef]
 
Hughes  AJ;  Daniel  SE;  Kilford  L  et al:  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.  J Neurol Neurosurg Psychiatry 2002; 55:181–184
[CrossRef]
 
Peto  V;  Jenkinson  C;  Fitzpatrick  R  et al:  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.  Qual Life Res 1995; 4:241–248
[PubMed]
[CrossRef]
 
Beck  AT;  Steer  R;  Brown  G:  The Beck Depression Inventory-II .  San Antonio, Tex,  Psychological Corporation, 1996
 
Spielberger  CD:  Manual for the State-Trait Anxiety Inventory .  Palo Alto, Calif,  Consulting Psychologists Press, 1983
 
Starkstein  SE;  Mayberg  HS;  Preziosi  TJ  et al:  Reliability, validity, and clinical correlates of apathy in Parkinson's disease.  J Neuropsychiatry Clin Neurosci 1992; 4:134–139
[PubMed]
 
Patton  JH;  Stanford  MS;  Barratt  ES:  Factor structure of the Barratt Impulsiveness Scale.  J Clin Psychol 1995; 51:768–774
[PubMed]
[CrossRef]
 
Goodman  WK;  Price  LH;  Rasmussen  SA  et al:  The Yale-Brown Obsessive Compulsive Scale. I: development, use, and reliability.  Arch Gen Psychiatry 1989; 46:1006–1011
[PubMed]
[CrossRef]
 
Young  RC;  Biggs  JT;  Ziegler  VE  et al:  A rating scale for mania: reliability, validity and sensitivity.  Br J Psychiatry 1978; 133:429–435
[PubMed]
[CrossRef]
 
Lesieur  HR;  Blume  SB:  The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers.  Am J Psychiatry 1987; 144:1184–1188
[PubMed]
 
Kalichman  SC;  Rompa  D:  The sexual compulsivity scale: further development and use with HIV-positive persons.  J Pers Assess 2001; 76:379–395
[PubMed]
[CrossRef]
 
Frost  RO;  Steketee  G;  Grisham  J:  Measurement of compulsive hoarding: saving inventory-revised.  Behav Res Ther 2004; 42:1163–1182
[PubMed]
[CrossRef]
 
Demetrovics  Z;  Szeredi  B;  Rózsa  S:  The three-factor model of internet addiction: the development of the Problematic Internet Use Questionnaire.  Behav Res Methods 2008; 40:563–574
[PubMed]
[CrossRef]
 
Valence  G;  d'Astous  A;  Fortier  L:  Compulsive buying: concept and measurement.  J Consum Policy 1988; 11:419–433
[CrossRef]
 
Mond  JM;  Hay  PJ;  Rodgers  B  et al:  Validity of the Eating Disorder Examination Questionnaire (EDE-Q) in screening for eating disorders in community samples.  Behav Res Ther 2004; 42:551–567
[PubMed]
[CrossRef]
 
Stice  E;  Telch  CF;  Rizvi  SL:  Development and validation of the eating disorder diagnostic scale: a brief self-report measure of anorexia, bulimia, and binge-eating disorder.  Psychol Assess 2000; 12:123–131
[PubMed]
[CrossRef]
 
Evans  AH;  Pavese  N;  Lawrence  AD  et al:  Compulsive drug use linked to sensitized ventral striatal dopamine transmission.  Ann Neurol 2006; 59:852–858
[PubMed]
[CrossRef]
 
Fan  W;  Ding  H;  Ma  J  et al:  Impulse control disorders in Parkinson's disease in a Chinese population.  Neurosci Lett 2009; 465:6–9
[PubMed]
[CrossRef]
 
Evans  AH;  Katzenschlager  R;  Pavious  D  et al:  Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.  Mov Disord 2004; 19:397–405
[PubMed]
[CrossRef]
 
Voon  V;  Hassan  K;  Zurowski  M  et al:  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.  Neurology 2006; 67:1254–1257
[PubMed]
[CrossRef]
 
Gallagher  DA;  O'Sullivan  SS;  Evans  AH  et al:  Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation: an analysis of published case series.  Mov Disord 2007; 22:1757–1763
[PubMed]
[CrossRef]
 
Ardouin  C;  Voon  V;  Worbe  Y  et al:  Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.  Mov Disord 2006; 21:1941–1946
[PubMed]
[CrossRef]
 
Frank  MJ;  Samanta  J;  Moustafa  AA  et al:  Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism.  Science 2007; 318:1309–1312
[PubMed]
[CrossRef]
 
Hälbig  TD;  Tse  W;  Frisina  PG  et al:  Subthalamic deep brain stimulation and impulse control in Parkinson's disease.  Eur J Neurol 2009; 16:493–497
[PubMed]
[CrossRef]
 
Smending  HM;  Goudriaan  AE;  Foncke  EM  et al:  Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson's disease.  J Neurol Neurosurg Psychiatry 2007; 78:517–519
[PubMed]
[CrossRef]
 
Okun  MS;  Fernandez  HH;  Wu  SS  et al:  Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus internal deep brain stimulation: the compare trial.  Ann Neurol 2009; 65:586–595
[PubMed]
[CrossRef]
 
Zahodne  LB;  Okun  MS;  Foote  KD  et al:  Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus.  J Neurol 2009; 256:1321–1329
[PubMed]
[CrossRef]
 
Winter  C;  Lemke  C;  Sohr  R  et al:  High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat.  Exp Brain Res 2008; 185:497–507
[PubMed]
[CrossRef]
 
Walker  HC;  Lyerly  M;  Cutter  G  et al:  Weight changes associated with unilateral STN DBS and advanced PD.  Parkinsonism Relat Disord 2009; 15:709–711
[PubMed]
[CrossRef]
 
Montaurier  C;  Morio  B;  Bannier  S  et al:  Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.  Brain 2007; 130:1808–1018
[PubMed]
[CrossRef]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Web of Science® Times Cited: 14

Related Content
Articles
Books
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 52.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 27.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 44.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 44.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 14.  >
Topic Collections
Psychiatric News
PubMed Articles